[ad_1]

BACKGROUND:

Medicinal  cannabis use is topical in the media in Ireland. A current Wellness Solutions Regulatory Authority assessment, on the other hand, has encouraged against its use for individuals with chronic discomfort. This is regardless of proof for its effectiveness in this patient’s cohort and the inadequate discomfort management of these individuals.

AIM:

The aim of this study was to evaluate the attitudes of Irish individuals with chronic discomfort towards medicinal  cannabis.

Procedures:

Soon after institutional ethics committee approval, a 12-item questionnaire (excluding demographics) was randomly assigned to individuals attending a chronic discomfort clinic (University Hospital Limerick). The questionnaire was developed to incorporate patient’s attitudes on a wide variety of medicinal  cannabis related subjects.

Outcomes:

Ninety-six adult individuals have been surveyed. 88.54% agreed that  cannabis should be legalised for chronic discomfort medicinal purposes. 80.21% believed it would have wellness positive aspects for them and 73.96% agreed it would be socially acceptable to use  cannabis for this goal. 33.33% perceived  cannabis to be addictive whilst 68.75% would be prepared to attempt it if prescribed by a healthcare professional.

CONCLUSIONS:

The study highlights the attitudes of chronic discomfort patients in Ireland towards medicinal  cannabis. It shows their need to have healthcare cannabis legalised for chronic discomfort and that they view it as a reasonable discomfort management choice.

[ad_2]